Cures Start Here. At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutchs pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nations first cancer prevention research program, as well as the clinical coordinating center of the Womens Health Initiative and the international headquarters of the HIV Vaccine Trials Network. Careers Start Here.
The Stem Cell and Gene Therapy (SCGT) program is recruiting a Research Technician II with a focus on bench research. Duties may include processing and analysis of primary blood and tissue samples for flow cytometry, PCR, sterile cell culture work with cell lines and primary cells, ELISA assays.
The position involves additional responsibilities, such as culture/analysis of cells infected with HIV and related viruses. The candidate should be motivated to participate in sample processing and analysis from preclinical modeling experiments. This position affords the motivated technician an opportunity to develop/utilize both tissue culture and molecular biology skills. The candidate must also be comfortable working with potentially infectious material and biosafety level 2+ techniques.
A Bachelor'sdegree is required/Masters degree is preferred, in biological science with at least two years of laboratory experience.
Candidates with excellent organizational andcommunication skills (written and oral)plus an ability to workwell in a multidisciplinary team environment are encouraged to apply.
To be successful in this position, thecandidate must be highly motivated,possess ahigh level of initiative and attention to details.
They must also be capable of working independently on multiple projects in a team environment.
Demonstrated proficiency in muticolor flow cytometry, and quantitative PCR is required.
Experience with cell culture, and molecular biology techniques is strongly desired.
Previous experience in cytotoxicity assays, ELISA, radiation work is desired, but not required.
Knowledge or experience maintaining and ordering materials is preferred in addition to excellent record keeping skills.
The ideal candidate would be familiar with computer programs including Microsoft Office, FlowJo, Graphpad Prism, and/or similar products.
We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We are proud to be an Equal Opportunity and VEVRAA Employer. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. If due to a disability you need assistance/and or a reasonable accommodation during the application or recruiting process, please send a request to our Employee Services Center at firstname.lastname@example.org or by calling 206-667-4700.
At Fred Hutchinson Cancer Research Center, teams of world-renowned scientists and humanitarians work together to prevent, diagnose and treat cancer, HIV/AIDS and other diseases. Researchers are discovering new ways to detect cancers earlier, improve treatments, and learn how to prevent cancers from growing. Although Fred Hutchinson opened its doors in 1975, its history began about 20 years before that. In 1962 Fred Hutchinson envisioned a center devoted to studying cancer, a disease that took his brother’s life. Today Fred Hutchinson is contributing to the next waves of breakthrough treatments and prevention strategies. Fred Hutchinson collaborates with the Seattle Cancer Alliance, the National Cancer Institute, and the University of Washington.